Managing infective endocarditis in the elderly: new issues for an old disease

References

• Selton-SutyCCélardMLe MoingVPreeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based surveyClin Infect Dis20125491230123922492317
   PubMed Web of Science ®Google Scholar
• SlipczukLCodolosaJNDavilaCDInfective endocarditis epidemiology over five decades: a systematic reviewPloS One2013812e8266524349331
   PubMed Web of Science ®Google Scholar
• Ramírez-DuqueNGarcía-CabreraEIvanova-GeorgievaRSurgical treatment for infective endocarditis in elderly patientsJ Infect201163213113821679726
   PubMed Web of Science ®Google Scholar
• LopezJRevillaAVilacostaIAge-dependent profile of left-sided infective endocarditis: a 3-center experienceCirculation2010121789289720142448
   PubMed Web of Science ®Google Scholar
• RemadiJPNadjiGGoissenTZomvuamaNASorelCTribouilloyCInfective endocarditis in elderly patients: clinical characteristics and outcomeEur J Cardiothorac Surg200935112312919062301
   PubMed Web of Science ®Google Scholar
• Durante-MangoniEBradleySSelton-SutyCCurrent features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort StudyArch Intern Med2008168192095210318955638
   PubMedGoogle Scholar
• HighKPBradleySLoebMPalmerRQuagliarelloVYoshikawaTA new paradigm for clinical investigation of infectious syndromes in older adults: assessment of functional status as a risk factor and outcome measureClin Infect Dis200540111412215614700
   PubMed Web of Science ®Google Scholar
• BaddourLMEpsteinAEEricksonCCUpdate on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart AssociationCirculation2010121345847720048212
   PubMed Web of Science ®Google Scholar
• GouldFKDenningDWElliottTSJGuidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial ChemotherapyJ Antimicrob Chemother201267226928922086858
   PubMed Web of Science ®Google Scholar
• HabibGLancellottiPAntunesMJ2015 ESC guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)Eur Heart J201536443075312826320109
   PubMed Web of Science ®Google Scholar
• BaddourLMWilsonWRBayerASInfective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart AssociationCirculation2015132151435148626373316
   PubMed Web of Science ®Google Scholar
• DelahayeFGouletVLacassinFCharacteristics of infective endocarditis in France in 1991. A 1-year surveyEur Heart J19951633944017789383
   PubMed Web of Science ®Google Scholar
• HoenBDuvalXInfective endocarditisN Engl J Med2013369878523964952
   PubMed Web of Science ®Google Scholar
• FerreirosENacinovichFCasabéJHEpidemiologic, clinical, and microbiologic profile of infective endocarditis in Argentina: a national survey. The Endocarditis Infecciosa en la República Argentina-2 (EIRA-2) StudyAm Heart J2006151254555216442929
   PubMed Web of Science ®Google Scholar
• BenitoNMiróJMde LazzariEHealth care-associated native valve endocarditis: importance of non-nosocomial acquisitionAnn Intern Med2009150958659419414837
   PubMed Web of Science ®Google Scholar
• CabellCHJollisJGPetersonGEChanging patient characteristics and the effect on mortality in endocarditisArch Intern Med20021621909411784225
   PubMedGoogle Scholar
• DhawanVKInfective endocarditis in elderly patientsCurr Infect Dis Rep20035428529212866978
   PubMedGoogle Scholar
• Di SalvoGThunyFRosenbergVEndocarditis in the elderly: clinical, echocardiographic, and prognostic featuresEur Heart J200324171576158312927193
   PubMed Web of Science ®Google Scholar
• GregoratosGInfective endocarditis in the elderly: diagnosis and managementAm J Geriatr Cardiol200312318318912732814
   PubMedGoogle Scholar
• Selton-SutyCHoenBGrentzingerAClinical and bacteriological characteristics of infective endocarditis in the elderlyHeart Br Card Soc1997773260263
   Web of Science ®Google Scholar
• Amat-SantosIJMessika-ZeitounDEltchaninoffHInfective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registryCirculation2015131181566157425753535
   PubMed Web of Science ®Google Scholar
• PericasJMLlopisJCerveraCInfective endocarditis in patients with an implanted transcatheter aortic valve: clinical characteristics and outcome of a new entityJ Infect201570656557625561168
   PubMed Web of Science ®Google Scholar
• VerhagenDWMHermanidesJKorevaarJCHealth-related quality of life and posttraumatic stress disorder among survivors of left-sided native valve endocarditisClin Infect Dis200948111559156519392637
   PubMed Web of Science ®Google Scholar
• McMillanGJHubbardREFrailty in older inpatients: what physicians need to knowQJM2012105111059106522753676
   PubMed Web of Science ®Google Scholar
• KappeteinAPHeadSJGénéreuxPUpdated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus documentEur Heart J201233192403241823026477
   PubMed Web of Science ®Google Scholar
• FriedLPTangenCMWalstonJFrailty in older adults: evidence for a phenotypeJ Gerontol2001563M146M156
   Google Scholar
• Rodriguez VillarrealIOrtegaOHinostrozaJGeriatric assessment for therapeutic decision-making regarding renal replacement in elderly patients with advanced chronic kidney diseaseNephron Clin Pract20141281–2737825378358
   PubMedGoogle Scholar
• FaulknerCMCoxHLWilliamsonJCUnique aspects of antimicrobial use in older adultsClin Infect Dis2005407997100415824992
   PubMed Web of Science ®Google Scholar
• FraisseTGras AygonCPaccalinMAminoglycosides use in patients over 75 years oldAge Ageing201443567668124590569
   PubMed Web of Science ®Google Scholar
• SandoeJAPatelPABaigMWWestRWhat is the effect of penicillin dosing interval on outcomes in streptococcal infective endocarditis?J Antimicrob Chemother201368112660266323766487
   PubMed Web of Science ®Google Scholar
• HughesDWFreiCRMaxwellPRContinuous versus intermittent infusion of oxacillin for treatment of infective endocarditis caused by methicillin-susceptible Staphylococcus aureusAntimicrob Agents Chemother20095352014201919258261
   PubMed Web of Science ®Google Scholar
• CataldoMATacconelliEGrilliEPeaFPetrosilloNContinuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysisJ Antimicrob Chemother2012671172422028203
   PubMed Web of Science ®Google Scholar
• LeeC-HTsaiC-YLiC-CChienC-CLiuJ-WTeicoplanin therapy for MRSA bacteraemia: a retrospective study emphasizing the importance of maintenance dosing in improving clinical outcomesJ Antimicrob Chemother201570125726325190719
   PubMed Web of Science ®Google Scholar
• FowlerVGBoucherHWCoreyGRDaptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureusN Engl J Med2006355765366516914701
   PubMed Web of Science ®Google Scholar
• KonychevAHeepMMoritzRKCSafety and efficacy of daptomycin as first-line treatment for complicated skin and soft tissue infections in elderly patients: an open-label, multicentre, randomized phase IIIb trialDrugs Aging2013301082983623990341
   PubMed Web of Science ®Google Scholar
• PaulMLadorAGrozinsky-GlasbergSLeiboviciLBeta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsisCochrane Database Syst Rev20141CD00334424395715
   PubMed Web of Science ®Google Scholar
• Fernández-HidalgoNAlmiranteBGavaldàJAmpicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditisClin Infect Dis20135691261126823392394
   PubMed Web of Science ®Google Scholar
• PericasJMCerveraCdel RioAChanges in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxoneClin Microbiol Infect20142012O1075O108325040215
   PubMed Web of Science ®Google Scholar
• NicolauDPFreemanCDBelliveauPPNightingaleCHRossJWQuintilianiRExperience with a once-daily aminoglycoside program administered to 2,184 adult patientsAntimicrob Agents Chemother19953936506557793867
   PubMed Web of Science ®Google Scholar
• MurryKRMcKinnonPSMitrzykBRybakMJPharmacodynamic characterization of nephrotoxicity associated with once-daily aminoglycosidePharmacotherapy199919111252126010555931
   PubMed Web of Science ®Google Scholar
• RavehDKopytMHiteYRudenskyBSonnenblickMYinnonAMRisk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosidesQJM200295529129711978900
   PubMed Web of Science ®Google Scholar
• DrusanoGLAmbrosePGBhavnaniSMBertinoJSNafzigerANLouieABack to the future: using aminoglycosides again and how to dose them optimallyClin Infect Dis200745675376017712761
   PubMed Web of Science ®Google Scholar
• FoltzFDucherMRougierFEfficacy and toxicity of aminoglycoside therapy in the elderly: combined effect of both once-daily regimen and therapeutic drug monitoringPathol Biol (Paris)200250422723212085667
   PubMedGoogle Scholar
• AmodeoMRClulowTLainchburyJOutpatient intravenous treatment for infective endocarditis: safety, effectiveness and one-year outcomesJ Infect200959638739319766136
   PubMed Web of Science ®Google Scholar
• CerveraCdel RíoAGarcíaLEfficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective studyEnfermedades Infecc Microbiol Clínica2011298587592
   Web of Science ®Google Scholar
• PartridgeDGO’BrienEChapmanALNOutpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years’ experience at a UK centrePostgrad Med J201288104137738122366395
   PubMed Web of Science ®Google Scholar
• DuncanCJABarrDAHoASharpESempleLSeatonRARisk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditisJ Antimicrob Chemother20136871650165423475647
   PubMed Web of Science ®Google Scholar
• LacroixARevestMPatrat-DelonSOutpatient parenteral antimicrobial therapy for infective endocarditis: a cost-effective strategyMed Mal Infect201444732733025022891
   PubMed Web of Science ®Google Scholar
• TiceADRehmSJDalovisioJRPractice guidelines for outpatient parenteral antimicrobial therapyClin Infect Dis200438121651167115227610
   PubMed Web of Science ®Google Scholar
• Dardaine-GiraudVLamandéMConstansTHypodermoclysis: benefits and indications in geriatricsRev Med Int2005268643650
   Web of Science ®Google Scholar
• Frisoli JuniorAde PaulaAPFeldmanDNasriFSubcutaneous hydration by hypodermoclysis. A practical and low cost treatment for elderly patientsDrugs Aging200016431331910874526
   PubMed Web of Science ®Google Scholar
• RemingtonRHultmanTHypodermoclysis to treat dehydration: a review of the evidenceJ Am Geriatr Soc200755122051205517971137
   PubMed Web of Science ®Google Scholar
• ForestierEPaccalinMRoubaud-BaudronCFraisseTGavazziGGaillatJSubcutaneously administered antibiotics: a national survey of current practice from the French infectious diseases (SPILF) and geriatric medicine (SFGG) society networksClin Microbiol Infect201521437025658521
   PubMed Web of Science ®Google Scholar
• BornerKLodeHHampelBPfeufferMKoeppePComparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administrationChemotherapy19853142372454028870
   PubMed Web of Science ®Google Scholar
• BricaireFCastaingJLPocidaloJJVildeJLPharmacocinétique et tolérance de la ceftriaxone après injection sous-cutanée. [Pharmacokinetics and tolerance of ceftriaxone after subcutaneous administration]Pathol Biol (Paris)1988365 Pt 27027053054751
   PubMedGoogle Scholar
• HarbGLebelFBattikhaJThackaraJWSafety and pharmacokinetics of subcutaneous ceftriaxone administered with or without recombinant human hyaluronidase (rHuPH20) versus intravenous ceftriaxone administration in adult volunteersCurr Med Res Opin201026227928819947907
   PubMed Web of Science ®Google Scholar
• GauthierDSchambachSCrouzetJSirvainSFraisseTSubcutaneous and intravenous ceftriaxone administration in patients more than 75 years of ageMed Mal Infect201444627528024932703
   PubMed Web of Science ®Google Scholar
• BarbotAVenisseNRayehFBouquetSDebaeneBMimozOPharmacokinetics and pharmacodynamics of sequential intravenous and subcutaneous teicoplanin in critically ill patients without vasopressorsIntensive Care Med20032991528153412856119
   PubMed Web of Science ®Google Scholar
• CarpentierERoméoBEl SamadYGeslin-LichtenbergerLMaingourdYTourneuxPSubcutaneous teicoplanin for children with infectious endocarditisArch Ped2013207775778
   Web of Science ®Google Scholar
• LengBSauxMCLatrilleJComparative pharmacokinetics of amikacin after intravenous, intramuscular and subcutaneous administrationNouv Presse Med197984234213425537887
   PubMedGoogle Scholar
• PlantinPMaheMLe Noac’hELe RoyJPCutaneous necroses after subcutaneous injections of amikacinPresse Med1993222913668248070
   PubMed Web of Science ®Google Scholar
• PensoDDelfraissyJFPham VanTDormontJSkin necrosis following administration of subcutaneous gentamicinPresse Med19841325157515766234546
   PubMed Web of Science ®Google Scholar
• Al-OmariACameronDWLeeCCorrales-MedinaVFOral antibiotic therapy for the treatment of infective endocarditis: a systematic reviewBMC Infect Dis20141414024624933
   PubMed Web of Science ®Google Scholar
• LalaniTChuVHParkLPCecchiEIn-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditisJAMA Intern Med2013173161495150423857547
   PubMed Web of Science ®Google Scholar
• GacaJGShengSDaneshmandMAOutcomes for endocarditis surgery in North America: a simplified risk scoring systemJ Thorac Cardiovasc Surg2011141198106e1221168017
   PubMed Web of Science ®Google Scholar
• De FeoMCotrufoMCarozzaAThe need for a specific risk prediction system in native valve infective endocarditis surgeryScientific World Journal2012201230757122536134
   PubMed Web of Science ®Google Scholar
• NashefSARoquesFMichelPGauducheauELemeshowSSalamonREuropean system for cardiac operative risk evaluation (EuroSCORE)Eur J Cardio-Thorac Surg1999161913
   PubMed Web of Science ®Google Scholar
• ShahianDMO’BrienSMFilardoGThe Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1 – coronary artery bypass grafting surgeryAnn Thorac Surg2009881 SupplS2S2219559822
   PubMed Web of Science ®Google Scholar
• BernsteinADParsonnetVBedside estimation of risk as an aid for decision-making in cardiac surgeryAnn Thorac Surg200069382382810750767
   PubMed Web of Science ®Google Scholar
• AfilaloJMottilloSEisenbergMJAddition of frailty and disability to cardiac surgery risk scores identifies elderly patients at high risk of mortality or major morbidityCirc Cardiovasc Qual Outcomes20125222222822396586
   PubMed Web of Science ®Google Scholar